If your email program has trouble displaying this email, view as a webpage.

Update: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

Today, the U.S. Food and Drug Administration (FDA) updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to:

• add Luminostics, Inc. Clip COVID Rapid Antigen Test as a test expected to have reduced performance for the SARS-CoV-2 Omicron Variant and Sub-Variants.

Questions?

If you have questions about this update, email COVID19DX@fda.hhs.gov.